rs139505007
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001387283.1(SMARCA4):c.4590C>G(p.Tyr1530*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. Y1530Y) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001387283.1 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.4590C>G | p.Tyr1530* | stop_gained | Exon 32 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
| SMARCA4 | ENST00000344626.10 | c.4494C>G | p.Tyr1498* | stop_gained | Exon 31 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
| SMARCA4 | ENST00000643549.1 | c.4500C>G | p.Tyr1500* | stop_gained | Exon 31 of 35 | ENSP00000493975.1 | ||||
| SMARCA4 | ENST00000541122.6 | c.4404C>G | p.Tyr1468* | stop_gained | Exon 31 of 35 | 5 | ENSP00000445036.2 | |||
| SMARCA4 | ENST00000643296.1 | c.4404C>G | p.Tyr1468* | stop_gained | Exon 30 of 34 | ENSP00000496635.1 | ||||
| SMARCA4 | ENST00000644737.1 | c.4404C>G | p.Tyr1468* | stop_gained | Exon 30 of 34 | ENSP00000495548.1 | ||||
| SMARCA4 | ENST00000589677.5 | c.4401C>G | p.Tyr1467* | stop_gained | Exon 31 of 35 | 5 | ENSP00000464778.1 | |||
| SMARCA4 | ENST00000643995.1 | c.3915C>G | p.Tyr1305* | stop_gained | Exon 28 of 32 | ENSP00000496004.1 | ||||
| SMARCA4 | ENST00000644963.1 | c.3144C>G | p.Tyr1048* | stop_gained | Exon 24 of 28 | ENSP00000495599.1 | ||||
| SMARCA4 | ENST00000644065.1 | c.3126C>G | p.Tyr1042* | stop_gained | Exon 23 of 27 | ENSP00000493615.1 | ||||
| SMARCA4 | ENST00000642350.1 | c.2988C>G | p.Tyr996* | stop_gained | Exon 23 of 27 | ENSP00000495355.1 | ||||
| SMARCA4 | ENST00000643857.1 | c.2856C>G | p.Tyr952* | stop_gained | Exon 22 of 25 | ENSP00000494159.1 | ||||
| SMARCA4 | ENST00000538456.4 | c.660C>G | p.Tyr220* | stop_gained | Exon 5 of 8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.Y1530* pathogenic mutation (also known as c.4590C>G), located in coding exon 31 of the SMARCA4 gene, results from a C to G substitution at nucleotide position 4590. This changes the amino acid from a tyrosine to a stop codon within coding exon 31. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at